SMARCA4 and nasal cavity and paranasal sinus carcinoma: Being unified by SMARCA4 loss, TCS and SMARCA4-deficient sinonasal carcinoma might be looked at as different morphotypes on the spectrum of same entity rather than two independent entities [32, 39].